PMC5771910_01
June 2013; first staging with computed tomography.
CCR3-6-56-g001.jpg
PMC5771910_01_CCR3-6-56-g001.jpg
ccr31107-fig-0001
A following Positron emission tomography (PET/TC) confirmed the malignant nature of the oropharyngeal lesion, which appeared as an area showing high uptake (SUV 12.6); both the lymph node (SUV: 10) and lung lesions (SUV: 6) also strongly pick up the FDG (fluoro-deoxy-glucose) (Fig. 1).
September 2013; first restaging after induction chemotherapy.
CCR3-6-56-g002.jpg
PMC5771910_01_CCR3-6-56-g002.jpg
ccr31107-fig-0002
The lymph node lesion appeared strongly reduced when compared with previous CT scan (Fig. 2).
February 2014; second restaging after chemoradiation (CT scan).
CCR3-6-56-g003.jpg
PMC5771910_01_CCR3-6-56-g003.jpg
ccr31107-fig-0003
We judged the patient to be in complete response (CR) (Fig. 3), and we addressed him to a follow-up program.